Medical aid allowed to cap cancer drug benefit
08 October 2015 - 02:19
Bonitas Medical Scheme does not have to pay for a year's supply of the breast cancer drug Herceptin for one of its members. The final-appeal committee of the Council for Medical Schemes has ruled in favour of Bonitas, saying the plan chosen by the claimant, Veroney Judd-Stevens, of Pietermaritzburg, did not cover her for a year's supply of the drug.
This article is reserved for Sunday Times subscribers.
A subscription gives you full digital access to all Sunday Times content.
Please visit SundayTimes.co.za in your desktop to view our latest subscription options.
Already subscribed? Simply sign in below.
Sign InQuestions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.